References
- Acarregui A, Murua A, Pedraz JL, et al. A perspective on bioactive cell microencapsulation. BioDrugs 2012;26:283–301
- Calafiore R, Basta G. Clinical application of microencapsulated islets: actual prospectives on progress and challenges. Adv Drug Deliv Rev 2014;67–68:84–92
- Santos E, Pedraz JL, Hernandez RM, Orive G. Therapeutic cell encapsulation: ten steps towards clinical translation. J Control Release 2013;170:1–14
- Orive G, Santos E, Pedraz JL, Hernandez RM. Application of cell encapsulation for controlled delivery of biological therapeutics. Adv Drug Deliv Rev 2014;67–68:3–14
- Murua A, de Castro M, Orive G, et al. In vitro characterization and in vivo functionality of erythropoietin-secreting cells immobilized in alginate-poly-l-lysine-alginate microcapsules. Biomacromolecules 2007;8:3302–7
- Ngoc PK, Phuc PV, Nhung TH, et al. Improving the efficacy of type 1 diabetes therapy by transplantation of immunoisolated insulin-producing cells. Hum Cell 2011;24:86–95
- Luca G, Fallarino F, Calvitti M, et al. Xenograft of microencapsulated sertoli cells reverses T1DM in NOD mice by inducing neogenesis of beta-cells. Transplantation 2010;90:1352–7
- Klinge PM, Harmening K, Miller MC, et al. Encapsulated native and glucagon-like peptide-1 transfected human mesenchymal stem cells in a transgenic mouse model of Alzheimer's disease. Neurosci Lett 2011;497:6–10
- Grandoso L, Ponce S, Manuel I, et al. Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats. Int J Pharm 2007;343:69–78
- Markusen JF, Mason C, Hull DA, et al. Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beads. Tissue Eng 2006;12:821–30
- Orive G, De Castro M, Kong HJ, et al. Bioactive cell-hydrogel microcapsules for cell-based drug delivery. J Control Release 2009;135:203–10
- Shin H, Jo S, Mikos AG. Biomimetic materials for tissue engineering. Biomaterials 2003;24:4353–64
- Stupack DG, Cheresh DA. Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci 2002;115:3729–38
- Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci 2012;37:106–26
- Augst AD, Kong HJ, Mooney DJ. Alginate hydrogels as biomaterials. Macromol Biosci 2006;6:623–33
- Collier JH, Segura T. Evolving the use of peptides as components of biomaterials. Biomaterials 2011;32:4198–204
- Williams DF. The role of short synthetic adhesion peptides in regenerative medicine: the debate. Biomaterials 2011;32:4195–7
- Wang X, Ye K, Li Z, et al. Adhesion, proliferation, and differentiation of mesenchymal stem cells on RGD nanopatterns of varied nanospacings. Organogenesis 2013;9:280–6
- Xiang M, Lin Y, He G, et al. Correlation between biological activity and binding energy in systems of integrin with cyclic RGD-containing binders: a QM/MM molecular dynamics study. J Mol Model 2012;18:4917–27
- Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996;12:697–715
- Benoit YD, Groulx JF, Gagne D, Beaulieu JF. RGD-dependent epithelial cell-matrix interactions in the human intestinal crypt. J Signal Transduct 2012;2012:248759
- D'Souza SE, Ginsberg MH, Plow EF. Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif. Trends Biochem Sci 1991;16:246–50
- Bidarra SJ, Barrias CC, Fonseca KB, et al. Injectable in situ crosslinkable RGD-modified alginate matrix for endothelial cells delivery. Biomaterials 2011;32:7897–904
- Connelly JT, Garcia AJ, Levenston ME. Inhibition of in vitro chondrogenesis in RGD-modified three-dimensional alginate gels. Biomaterials 2007;28:1071–83
- Kim SY, Oh HK, Ha JM, et al. RGD-peptide presents anti-adhesive effect, but not direct pro-apoptotic effect on endothelial progenitor cells. Arch Biochem Biophys 2007;459:40–9
- Lagunas A, Comelles J, Martinez E, et al. Cell adhesion and focal contact formation on linear RGD molecular gradients: study of non-linear concentration dependence effects. Nanomedicine 2012;8:432–9
- Re'em T, Tsur-Gang O, Cohen S. The effect of immobilized RGD peptide in macroporous alginate scaffolds on TGFbeta1-induced chondrogenesis of human mesenchymal stem cells. Biomaterials 2010;31:6746–55
- Wang X, Yan C, Ye K, et al. Effect of RGD nanospacing on differentiation of stem cells. Biomaterials 2013;34:2865–74
- Roach P, Farrar D, Perry CC. Surface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistry. J Am Chem Soc 2006;128:3939–45
- Pierschbacher MD, Ruoslahti E. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J Biol Chem 1987;262:17294–8
- Houseman BT, Mrksich M. The microenvironment of immobilized Arg-Gly-Asp peptides is an important determinant of cell adhesion. Biomaterials 2001;22:943–55
- Bellis SL. Advantages of RGD peptides for directing cell association with biomaterials. Biomaterials 2011;32:4205–10
- Santos E, Garate A, Pedraz JL, et al. The synergistic effects of the RGD density and the microenvironment on the behavior of encapsulated cells: in vitro and in vivo direct comparative study. J Biomed Mater Res A 2014;102:3965–72
- Rowley JA, Mooney DJ. Alginate type and RGD density control myoblast phenotype. J Biomed Mater Res 2002;60:217–23
- Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999;20:45–53
- Comisar WA, Hsiong SX, Kong HJ, et al. Multi-scale modeling to predict ligand presentation within RGD nanopatterned hydrogels. Biomaterials 2006;27:2322–9
- Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980;210:908–10
- Dai W, Saltzman WM. Fibroblast aggregation by suspension with conjugates of poly(ethylene glycol) and RGD. Biotechnol Bioeng 1996;50:349–56
- Jiang LY, Lv B, Luo Y. The effects of an RGD-PAMAM dendrimer conjugate in 3D spheroid culture on cell proliferation, expression and aggregation. Biomaterials 2013;34:2665–73
- Koo LY, Irvine DJ, Mayes AM, et al. Co-regulation of cell adhesion by nanoscale RGD organization and mechanical stimulus. J Cell Sci 2002;115:1423–33
- Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996;12:697–15
- Orive G, Hernandez RM, Gascon AR, et al. Survival of different cell lines in alginate-agarose microcapsules. Eur J Pharm Sci 2003;18:23–30
- Sayyar B, Dodd M, Marquez-Curtis L, et al. Cell-matrix Interactions of Factor IX (FIX)-engineered human mesenchymal stromal cells encapsulated in RGD-alginate vs. fibrinogen-alginate microcapsules. Artif Cells Nanomed Biotechnol 2014;42:102–9
- Sayyar B, Dodd M, Wen J, et al. Encapsulation of factor IX-engineered mesenchymal stem cells in fibrinogen-alginate microcapsules enhances their viability and transgene secretion. J Tissue Eng 2012;3:2041731412462018
- Yasuhara T, Shingo T, Muraoka K, et al. Neurorescue effects of VEGF on a rat model of Parkinson's disease. Brain Res 2005;1053:10–8
- Neff JA, Tresco PA, Caldwell KD. Surface modification for controlled studies of cell-ligand interactions. Biomaterials 1999;20:2377–93
- Comisar WA, Kazmers NH, Mooney DJ, Linderman JJ. Engineering RGD nanopatterned hydrogels to control preosteoblast behavior: a combined computational and experimental approach. Biomaterials 2007;28:4409–17
- Bidarra SJ, Barrias CC, Barbosa MA, et al. Immobilization of human mesenchymal stem cells within RGD-grafted alginate microspheres and assessment of their angiogenic potential. Biomacromolecules 2010;11:1956–64
- Evangelista MB, Hsiong SX, Fernandes R, et al. Upregulation of bone cell differentiation through immobilization within a synthetic extracellular matrix. Biomaterials 2007;28:3644–55
- Li H, Frith J, Cooper-White JJ. Modulation of stem cell adhesion and morphology via facile control over surface presentation of cell adhesion molecules. Biomacromolecules 2014;15:43–52